Cargando…
Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
Despite the beneficial effect of myo-inositol on metabolic, hormonal, and reproductive parameters of polycystic ovary syndrome (PCOS) patients, 28% to 38% could be resistant to this treatment. The combination with the milk protein α-lactalbumin can be a useful therapeutic approach to overcome inosit...
Autores principales: | Kamenov, Zdravko, Gateva, Antoaneta, Dinicola, Simona, Unfer, Vittorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304700/ https://www.ncbi.nlm.nih.gov/pubmed/37367875 http://dx.doi.org/10.3390/metabo13060717 |
Ejemplares similares
-
Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
por: Montanino Oliva, Mario, et al.
Publicado: (2018) -
The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol
por: Guarnieri, Gabriella, et al.
Publicado: (2023) -
Inositols in PCOS
por: Kamenov, Zdravko, et al.
Publicado: (2020) -
Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate
por: Bizzarri, Mariano, et al.
Publicado: (2016) -
Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022)